title: Any place for depot triamcinolone in hay fever?
abstract: The prevalence of hay fever (seasonal allergic rhinitis) in the UK has been increasing; for instance, it doubled from 10 to 20 per 1000 people between the 1970s and 1980s. For a few patients with severe hay fever symptoms, it sometimes helps to give a systemic corticosteroid; one possible option is the injection of a long-acting corticosteroid, such as triamcinolone. We have previously concluded that systemic corticosteroids have only a limited role, that is, when complete control of severe symptoms is judged essential (e.g. for a wedding or exam). Here we reconsider the case for depot triamcinolone injections in the management of hay fever.
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D014221:Triamcinolone / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D005938:Glucocorticoids; D014221:Triamcinolone